semaglutide injection name for Seniors With Medicare Zydus Lifesciences Forms Co-Marketing Partnership

This is where post-GLP-1 joy becomes an innovation brief

Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity

The emergence of these compounds presents a difficult challenge for regulators

Patients planning surgery should discuss tirzepatide with their healthcare team, though recent guidance from the American Society of Anesthesiologists indicates most patients can continue GLP-1 receptor agonists perioperatively, with modifications only for those at high risk of gastrointestinal complications

However, it's essential to emphasize that tirzepatide's weight loss results are most pronounced when combined with a diet and exercise program, as changes in lifestyle habits are crucial for success